Q4 2022 Holdings
Filed 2023-02-14 | 13 holdings | $115.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $26.1M | 2,825,976 | 22.6% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $23.0M | 3,126,173 | 19.9% |
| Merus N V | COM | N5749R100 | $13.2M | 854,591 | 11.4% |
| Kinnate Biopharma Inc | COM | 49705R105 | $12.2M | 1,998,417 | 10.5% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $10.4M | 1,653,495 | 9.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $9.0M | 1,093,900 | 7.8% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $5.9M | 5,628,585 | 5.1% |
| Pardes Biosciences Inc | COM | 69945Q105 | $5.1M | 3,003,102 | 4.4% |
| Passage BIO Inc | COM | 702712100 | $4.6M | 3,355,917 | 4.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $3.9M | 784,158 | 3.4% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $1.2M | 2,291,133 | 1.0% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $830.6K | 64,739 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $284.9K | 25,325 | 0.2% |